Company: 

ViiV Healthcare

ViiV Healthcare

Niche's skilled medical writing team engaged with ViiV Healthcare to quickly and efficiently develop high quality documents to support their global outreach activities. This involved:

  • General editorial and medical writing support to aid in the development of effective patient outreach programmes and regulatory and medical affairs projects
  • Comms planning and drafting key manuscripts and guidance on effective message dissemination strategies
  • Delivery of bespoke data mining research projects to track patient access to HIV medicines
What our client said

"We frequently engaged Niche to providing editorial and medical writing support to partner organisations involved in our patient outreach programmes. We also engaged Niche to provide strategic in put on regulatory and medical affairs projects."

photophotophotophotophoto

Scott Purdon, Director Market Access

ViiV Healthcare




Project background
ViiV Healthcare is a global specialist company majority owned by GSK, with Pfizer and Shionogi as shareholders. ViiV is exclusively committed to HIV medicines and research, focusing on people living with HIV and AIDS. The company was established with one ambitious, clear goal: to end the HIV epidemic. In addition to exploring new ways to treat, prevent and ultimately find a cure for HIV, they are focusing on understanding how to bridge the gap between research and everyday clinical practice. ViiV’s pipeline is centred on integrase inhibitors, with a variety of other compounds, including broadly neutralising antibodies and capsid inhibitors. To date, their portfolio consists of 17 prescription medicines. Alongside R&D, ViiV is committed to improving access to HIV medicines and community initiatives that strengthen local healthcare services for people living with HIV.
Delivery

Niche and ViiV have had a longstanding collaboration, continuing from support provided to GSK's award winning Positive Action patient advocacy programme. Niche was invited to provide editorial and medical writing services to ViiV’s partner organisations involved in patient outreach programmes. In addition, ViiV also relied on Niche’s strategic input on various regulatory and medical affairs projects.

From very early on, ViiV’s specialist clinical ambitions were well served by Niche’s deep clinical expertise and patient-centric approach. The Niche team recognises that patient care should be paramount at every stage of clinical development. This ethos synergised well with ViiV’s patient outreach programmes.

ViiV faced major challenges in providing global access of essential medications to people living with HIV. Thus, ViiV deployed Niche’s research competencies to inform their global medications access and regulatory strategies. The team’s extensive experience in literature searches meant that they could quickly and flexibly provide ViiV with relevant information, appropriately targeted to their regulatory requirements.

Related Case studies

Medical writing

Specialising in the discovery and development of small-molecule drugs for oncology and central nervous system disorders.

Niche provided Astex with expert regulatory writing across their oncology pipeline, delivering clinical protocols, study.

read more
Medical writing

The FRAILOMIC initiative was an international research project

Niche built and coordinated the full communications strategy for this 20-institution European initiative, turning.

read more
Medical writing

Cleothena Enterprises Pty Ltd. is a forward-thinking biotechnology company focused on advancing innovative therapeutic solutions.

When stalled regulatory documentation threatened to derail their neurological programme, Cleothena turned to Niche —.

read more
Medical writing

BSH is the UK’s largest haematology organisation, promoting excellence within the field and supporting professional development.

Over a decade and 20+ guidelines later, Niche remains the BSH's trusted partner for raising haematology care standards.

read more
Medical writing

QC review of an IB update for uzatresgene autoleucel, one of Adaptimmune’s TCR-based therapies.

Niche delivered rigorous QC and medical writing support across Adaptimmune's full suite of regulatory documents, keeping.

read more
Medical writing

Nabriva Therapeutics is committed to developing new antibiotics to treat infectious diseases.

Niche supported Nabriva's antibiotic lefamulin from early clinical protocols all the way to FDA, EMA and Health Canada.

read more
Medical writing

Partnership with a clinical research organisation specialising in comprehensive data services for clinical trials.

For over a decade, Assign DMB relied on Niche as their embedded writing partner, seamlessly converting statistical.

read more
Medical writing

Providing regulatory and medical writing support to meet client needs

Niche served as the English-language regulatory writing backbone for this Nordic consultancy, producing IBs, IMPDs and.

read more

Get our latest news and publications

Sign up to our news letter

© 2025 Niche.org.uk     All rights reserved

HomePrivacy policy Corporate Social Responsibility